Event Brief
FDA Reviews Potentially Carcinogenic BHA Preservative
Filed: Feb 10, 2026 at 5:06 PM ET
Summary: The FDA is reviewing butylated hydroxyanisole to assess its safety.
WHO: Food and Drug Administration
WHAT: Review of butylated hydroxyanisole
WHEN: Feb 10, 2026 at 4:19 PM ET
WHERE: USA
WHY: To determine if it is safe for use
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →